Crossmark

Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1

Crossref DOI link: https://doi.org/10.1186/s13550-016-0247-y

Published Online: 2017-01-05

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dalmo, Johanna

Spetz, Johan

Montelius, Mikael

Langen, Britta

Arvidsson, Yvonne

Johansson, Henrik

Parris, Toshima Z.

Helou, Khalil

Wängberg, Bo

Nilsson, Ola

Ljungberg, Maria

Forssell-Aronsson, Eva
Funding

Funding for this research was provided by:

Vetenskapsrådet (21073)

Swedish Cancer Society (3427)

BioCARE - a National Strategic Research Program at University of Gothenburg

King Gustav V Jubilee Clinic Cancer Research Foundation (20131023)

Johan Jansson Foundation (20131126)

Stiftelsen Lars Hiertas Minne (20131126)

Wilhelm and Martina Lundgren Research Foundation (20130418)

Stiftelsen Assar Gabrielssons Fond (FB13-17, FB12-39)

Sahlgrenska University Hospital Research Funds (2014)
License Information

License valid from 2017-01-05

Document is current

Any future updates will be listed below